SAN DIEGO, June 02, 2025 -- BioAtla, Inc. (Nasdaq: BCAB) (the “Company”), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the...
Art Pappas to sit on a panel titled "Venture Funding" at the EDC BioTech 2008 conference at in Miami, FL
News | 04. 24. 2008
